Literature DB >> 31800203

Nanomedicines Lost in Translation.

Keegan Guidolin1,2,3, Gang Zheng2,4,3.   

Abstract

Nanomedicines have historically struggled to find clinical relevance and to achieve translation successfully. In this Perspective, we discuss possible reasons for this difficulty and highlight several key features of nanomedicines that are often overlooked by biomedical engineers. We present the notion of clinical multifunctionality as distinct from multifunctionality as it is traditionally described at the nanoscale and emphasize its importance through examples of nanomedicines that have demonstrated emergent clinical multifunctionality once translated. We also describe a phenomenon in which clinical multifunctionality results in diagonal translation after a nanomedicine is adopted by clinicians to serve as a solution for a clinical problem that it was not designed to solve. Biomedical engineers can take advantage of these phenomena to assist in achieving clinical translation of new nanomedicines.

Year:  2019        PMID: 31800203     DOI: 10.1021/acsnano.9b08659

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  7 in total

Review 1.  Current approaches of nanomedicines in the market and various stage of clinical translation.

Authors:  Xiaoting Shan; Xiang Gong; Jie Li; Jingyuan Wen; Yaping Li; Zhiwen Zhang
Journal:  Acta Pharm Sin B       Date:  2022-03-01       Impact factor: 14.903

Review 2.  Translational Applications of Hydrogels.

Authors:  Santiago Correa; Abigail K Grosskopf; Hector Lopez Hernandez; Doreen Chan; Anthony C Yu; Lyndsay M Stapleton; Eric A Appel
Journal:  Chem Rev       Date:  2021-05-03       Impact factor: 60.622

Review 3.  Targeting Trained Innate Immunity With Nanobiologics to Treat Cardiovascular Disease.

Authors:  Abraham J P Teunissen; Mandy M T van Leent; Geoffrey Prévot; Eliane E S Brechbühl; Carlos Pérez-Medina; Raphaël Duivenvoorden; Zahi A Fayad; Willem J M Mulder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-04-22       Impact factor: 10.514

4.  Dual drug-loaded nano-platform for targeted cancer therapy: toward clinical therapeutic efficacy of multifunctionality.

Authors:  Zhe Ma; Nan Li; Bing Zhang; YuYu Hui; Ying Zhang; Peng Lu; Jiaxin Pi; Zhidong Liu
Journal:  J Nanobiotechnology       Date:  2020-09-04       Impact factor: 10.435

Review 5.  Nanomedicine Strategies for Heating "Cold" Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC.

Authors:  Yuqi Yang; Tianjiao Zhao; Qiaohui Chen; Yumei Li; Zuoxiu Xiao; Yuting Xiang; Boyu Wang; Yige Qiu; Shiqi Tu; Yitian Jiang; Yayun Nan; Qiong Huang; Kelong Ai
Journal:  Adv Sci (Weinh)       Date:  2022-07-22       Impact factor: 17.521

6.  Effect of XlogP and hansen solubility parameters on the prediction of small molecule modified docetaxel, doxorubicin and irinotecan conjugates forming stable nanoparticles.

Authors:  Mei-Qi Xu; Ting Zhong; Xin Yao; Zhuo-Yue Li; Hui Li; Jing-Ru Wang; Zhen-Han Feng; Xuan Zhang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 7.  Drug Delivery Strategies and Biomedical Significance of Hydrogels: Translational Considerations.

Authors:  Neha Raina; Rakesh Pahwa; Jaydeep Bhattacharya; Alok K Paul; Veeranoot Nissapatorn; Maria de Lourdes Pereira; Sonia M R Oliveira; Karma G Dolma; Mohammed Rahmatullah; Polrat Wilairatana; Madhu Gupta
Journal:  Pharmaceutics       Date:  2022-03-05       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.